Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13801 - 13825 of 14784 in total
INT41 (also known as rAAV6-INT41) is a recombinant adeno-associated virus vector containing DNA encoding INT41 intrabody.
Investigational
RGX-181 consists of an adeno-associated virus serotype 9 (AAV9) vector designed to deliver the soluble lysosomal enzyme tripeptidyl peptidase I (TPP1) gene. Developed by REGENXBIO, it is being investigated for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease.
Investigational
Matched Description: … RGX-181 consists of an adeno-associated virus serotype 9 (AAV9) vector designed to deliver the soluble ... Developed by REGENXBIO, it is being investigated for the treatment of late-infantile neuronal ceroid …
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
RGLS-8429 is an investigational anti-miR-17 oligonucleotide.
Investigational
SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational
Matched Description: … SGN-1 is a genetically modified strain of _Salmonella enterica_ comprising methioninase. …
Briquilimab is a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit).
Investigational
Investigational
CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational
Matched Description: … GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of
SER-287 comprises healthy microbiome-derived Gram positive bacterial spores.
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Displaying drugs 13801 - 13825 of 14784 in total